Retractable Technologies, Inc.
$0.65
▲
3.29%
2026-04-21 09:14:01
www.retractable.com
ASE: RVP
Explore Retractable Technologies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$19.46 M
Current Price
$0.65
52W High / Low
$1.14 / $0.62
Stock P/E
—
Book Value
$2.48
Dividend Yield
1.18%
ROCE
-10.73%
ROE
-15.56%
Face Value
—
EPS
$-0.43
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
—
Beta
1.26
Debt / Equity
1.62
Current Ratio
6.57
Quick Ratio
4.78
Forward P/E
—
Price / Sales
0.52
Enterprise Value
$-15.48 M
EV / EBITDA
1.24
EV / Revenue
-0.4
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Pro-Dex, Inc. | $53.3 | 15.38 | $174.44 M | — | 22.96% | 30.87% | $70.26 / $23.47 | $12.97 |
| 2. | DENTSPLY SIRONA Inc. | $12.79 | — | $2.61 B | 5.5% | 6.17% | -36.43% | $17.18 / $9.85 | $6.71 |
| 3. | Repligen Corporation | $130.14 | 150.55 | $7.4 B | — | 1.48% | 2.4% | $175.77 / $109.66 | $37.39 |
| 4. | Jin Medical International Ltd. | $2.08 | 13.77 | $16.4 M | — | 2.06% | 4.75% | $19.7 / $1.64 | $3.79 |
| 5. | Alcon Inc. | $77.24 | — | $30.37 B | 0.45% | 4.77% | 4.5% | $81.92 / $56.44 | $45.2 |
| 6. | Envista Holdings Corporation | $27.85 | 97.1 | $4.56 B | — | 4.89% | 1.56% | $30.42 / $14.72 | $18.96 |
| 7. | NEXGEL, Inc. | $0.64 | — | $6.98 M | — | -41.75% | -52.74% | $2.99 / $0.56 | $0.64 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 9.44 M | 10.09 M | 10.45 M | 8.3 M | 9.07 M | — |
| Operating Profit | -0.81 M | -3.65 M | -3.66 M | -3.19 M | -1.32 M | — |
| Net Profit | -2.35 M | 0.37 M | -0.09 M | -10.5 M | 3.77 M | — |
| EPS in Rs | -0.08 | 0.01 | -0 | -0.35 | 0.13 | -0.07 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 38.27 M | 33.05 M | 43.6 M | 94.82 M |
| Operating Profit | -14.27 M | -15.2 M | -5.26 M | 2.98 M |
| Net Profit | -12.57 M | -11.89 M | -7.01 M | 5.08 M |
| EPS in Rs | -0.42 | -0.4 | -0.23 | 0.17 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 142.63 M | 160.72 M | 179.67 M | 195.67 M |
| Total Liabilities | 68.26 M | 73.55 M | 80.38 M | 89.13 M |
| Equity | 74.38 M | 87.17 M | 99.29 M | 106.54 M |
| Current Assets | 63.08 M | 73.27 M | 77.65 M | 88.81 M |
| Current Liabilities | 9.6 M | 8.78 M | 9.38 M | 12.14 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -7.06 M | -11.56 M | 2.77 M | 16.77 M |
| Investing CF | 5.98 M | 3.66 M | -10.76 M | -31.2 M |
| Financing CF | -0.57 M | -0.54 M | 0.94 M | 4.99 M |
| Free CF | -7.6 M | -13 M | 1.91 M | -0.06 M |
| Capex | -0.54 M | -1.44 M | -0.85 M | -16.83 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -24.19% | -54.02% | — | — |
| Earnings Growth % | -69.54% | -238.05% | — | — |
| Profit Margin % | -35.97% | -16.08% | 5.36% | — |
| Operating Margin % | -46.01% | -12.07% | 3.14% | — |
| Gross Margin % | -3.11% | 20.89% | 29.8% | — |
| EBITDA Margin % | 12.62% | -2.84% | 10.48% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.